Turn Therapeutics (TTRX) Current Leases (2024 - 2026)

Turn Therapeutics (TTRX) posted quarterly Current Leases of $47795.0 for Q1 2026, up 3.24% quarter-over-quarter from $46295.0 in Q4 2025.

Turn Therapeutics (TTRX) Current Leases (2024 - 2026) Analysis & Trends

Turn Therapeutics' Current Leases history runs 3 years deep, the most recent figure standing at $47795.0 for Q1 2026.

In Q1 2026, Current Leases changed N/A year-over-year to $47795.0; the TTM figure through Mar 2026 stood at $47795.0 (changed N/A YoY), while the FY2025 annual figure was $46295.0, up 13.86% from the prior year.
Current Leases for Q1 2026 stood at $47795.0, up from $46295.0 in the prior quarter.
The five-year high for Current Leases was $47795.0 in Q1 2026, with the low at $40660.0 in Q4 2024.
The 3-year median for Current Leases is $45562.0 (2025), against an average of $44894.8.
Peak annual rise in Current Leases reached 13.86% in 2025, while the deepest fall reached 13.86% in 2025.
Turn Therapeutics' Current Leases stood at $40660.0 in 2024, then climbed by 13.86% to $46295.0 in 2025, then advanced by 3.24% to $47795.0 in 2026.
Business Quant data shows TTRX's Current Leases at $47795.0 in Q1 2026, $46295.0 in Q4 2025, and $44829.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	720.00 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	11.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	16.75 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	21.95 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	2.24 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	45.93 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.27 Mn
10	Turn Therapeutics	285.07 Mn	285.07 Mn	-	49,329.00

Download Data